Debate surrounds the validity of patch testing for allergic contact dermatitis in patients taking immunosuppressants and the extent to which these medications suppress patch test reactions. Previous studies have demonstrated that corticosteroids can suppress immune reactions measured in patch testing. Because immunomodulators are increasingly used, their impact on patch testing also requires evaluation.
Objectives
This study aimed to report patch test results in patients taking specific immunosuppressants and to review relevant literature.
Methods
A retrospective review of patients patch tested with the standard series at Mayo Clinic in Rochester, Minnesota, between January 1, 2008, and December 31, 2011, was conducted.
Conclusions
Positive patch test results occur during methotrexate therapy. How reactions would differ with no immunosuppression is unclear.
Get full access to this article
View all access options for this article.
References
1.
RustemeyerT, van HoogstratenIM, von BlombergME, et al.Mechanisms of irritant and allergic contact dermatitis. In: JohansenJD, FroschPJ, LepoittevinJP, eds. Contact Dermatitis. 5th ed. Berlin, Germany: Springer-Verlag; 2010: 43–90.
2.
MarksJG, BelsitoDV, DeLeoVA, et al.North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol, 1998; 38 (6 Pt 1): 911–918.
3.
WeeJS, WhiteJM, McFaddenJP, et al.Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis, 2010; 62 (3): 165–169.
4.
AnvedenI, LindbergM, AndersenKE, et al.Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis, 2004; 50 (5): 298–303.
5.
CondieMW, AdamsRM. Influence of oral prednisone on patch-test reactions to Rhus antigen. Arch Dermatol, 1973; 107 (4): 540–543.
6.
SulzbergerMB, WittenVH, ZimmermanEH. The effects of oral cortisone acetate on patch test reactions to eczematogenous contact allergens. Acta Derm Venereol Suppl (Stockh), 1952; 32 (29): 343–352.
7.
O’QuinnSE, IsbellKH. Influence of oral prednisone on eczematous patch test reactions. Arch Dermatol, 1969; 99 (4): 380–389.
8.
FeuermanE, LevyA. A study of the effect of prednisone and an antihistamine on patch test reactions. Br J Dermatol, 1972; 86 (1): 68–71.
9.
HigginsEM, McLellandJ, FriedmannPS, et al.Oral cyclosporin inhibits the expression of contact hypersensitivity in man. J Dermatol Sci, 1991; 2 (2): 79–83.
10.
FloriML, AndreassiL. Patch tests after cyclosporin A treatment in hyperreactive patients. Contact Dermatitis, 1994; 31 (5): 325.
11.
RosmarinD, BushM, ScheinmanPL. Patch testing a patient with allergic contact hand dermatitis who is taking infliximab. J Am Acad Dermatol, 2008; 59 (1): 145–147.
12.
PigattoP, CesaraniA, BarozziS, et al.Positive response to nickel and azathioprine treatment. J Eur Acad Dermatol Venereol, 2008; 22 (7): 891.
13.
RosmarinD, GottliebAB, AsarchA, et al.Patch-testing while on systemic immunosuppressants. Dermatitis, 2009; 20 (5): 265–270.
14.
WetterDA, DavisMD, YianniasJA, et al.Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998–2000. J Am Acad Dermatol, 2005; Sep;53 (3): 416–421.
15.
DavisMD, ScalfLA, YianniasJA, et al.Changing trends and allergens in the patch test standard series: a Mayo Clinic 5-year retrospective review, January 1, 2001, through December 31, 2005. Arch Dermatol, 2008; Jan;144 (1): 67–72.
16.
SmeenkG. Influence of local triamcinolone acetonide on patch test reactions to nickel sulfate. Dermatologica, 1975; 150 (2): 116–121.
17.
SukantoH, NaterJP, BleuminkE. Influence of topically applied corticosteroids on patch test reactions. Contact Dermatitis, 1981; 7 (4): 180–185.
18.
GreenC. The effect of topically applied corticosteroid on irritant and allergic patch test reactions. Contact Dermatitis, 1996; 35 (6): 331–333.
19.
ClarkRA, RietschelRL. 0.1% triamcinolone acetonide ointment and patch test responses. Arch Dermatol, 1982; 118 (3): 163–165.
20.
HaxthausenH. Studies on the local effect of various cortisone preparations on experimentally produced eczematous reactions. Acta Derm Venereol, 1956; 36 (6): 381–388.
21.
MarksJG, MillerJJ. Lookingbill and Marks’ Principles of Dermatology. 4th ed. Philadelphia, PA: Saunders Elsevier; 2006: 108.
22.
JacksonS, GilchristH, NesbittLTJr. Update on the dermatologic use of systemic glucocorticosteroids. Dermatol Ther, 2007; 20 (4): 187–205.
23.
PatelAA, SwerlickRA, McCallCO. Azathioprine in dermatology: the past, the present, and the future. J Am Acad Dermatol, 2006; 55 (3): 369–389.
